Alkermes plcALKS
Price$40.52Intrinsic value$23.1143% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.7B+7.1% YoYTTM through 30 Jun 2026
Net Income $66.1M-82.0% YoYTTM through 30 Jun 2026
Free Cash Flow $221.7MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin10.7%
Operating Margin7.0%
Net Margin4.0%

Returns

-3.8%ROE
1.5%ROA
2.4%ROIC

Balance Sheet Health

Debt / Equity0.86x
Current Ratio3.55x
Net Debt$998.4M
Cash & Equivalents$511.5M

Quality Metrics

Altman Z-Score2.13
Piotroski F-Score7 / 9
FCF Margin13.3%
Rule of 4022.7
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $1.5B
Diluted EPS$0.38TTM
'15'20'21'22'23'24'25
FY2025: $1.43

Dividend

No dividend

Capital Allocation

R&D Spend$391M
Capex Intensity1.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.